Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

BLADDER CANCER

Neoadjuvant anti-CTLA4 and anti-PD1 blockade in advanced urothelial cancer

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original article

  1. van Dijk, N. et al. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial. Nat. Med. https://doi.org/10.1038/s41591-020-1085-z (2020)

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rebecca Tregunna.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tregunna, R. Neoadjuvant anti-CTLA4 and anti-PD1 blockade in advanced urothelial cancer. Nat Rev Urol 17, 658 (2020). https://doi.org/10.1038/s41585-020-00399-0

Download citation

Search

Quick links